BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 9452344)

  • 21. Wilson's disease. An analysis of the cranial computerized tomographic appearances found in 60 patients and the changes in response to treatment with chelating agents.
    Williams FJ; Walshe JM
    Brain; 1981 Dec; 104(Pt 4):735-52. PubMed ID: 7326565
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Membranoproliferative glomerulonephritis in a patient with Wilson's disease.
    Ozçakar ZB; Ekim M; Ensari A; Kuloglu Z; Yüksel S; Acar B; Kirsaçlioglu C; Kansu A; Yalçinkaya F; Girgin N
    J Nephrol; 2006; 19(6):831-3. PubMed ID: 17173260
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Some therapeutic observations in Wilson's disease.
    Shoulson I; Goldblatt D; Plassche W; Wilson G
    Adv Neurol; 1983; 37():239-46. PubMed ID: 6858775
    [No Abstract]   [Full Text] [Related]  

  • 24. Patient with late-onset Wilson's disease: deterioration with penicillamine.
    Sohtaoglu M; Ergin H; Ozekmekçi S; Gökdemir S; Sonsuz A; Arici C
    Mov Disord; 2007 Jan; 22(2):290-1. PubMed ID: 17083099
    [No Abstract]   [Full Text] [Related]  

  • 25. Zinc treatment prevents lipid peroxidation and increases glutathione availability in Wilson's disease.
    Farinati F; Cardin R; D'inca R; Naccarato R; Sturniolo GC
    J Lab Clin Med; 2003 Jun; 141(6):372-7. PubMed ID: 12819634
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Wilson's disease studied with FDG and positron emission tomography.
    Hawkins RA; Mazziotta JC; Phelps ME
    Neurology; 1987 Nov; 37(11):1707-11. PubMed ID: 3499583
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Normal striatal glucose consumption in two patients with benign hereditary chorea as measured by positron emission tomography.
    Kuwert T; Lange HW; Langen KJ; Herzog H; Hefter H; Aulich A; Feinendegen LE
    J Neurol; 1990 Apr; 237(2):80-4. PubMed ID: 2141358
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Resolution of Wing-Beating Tremor and Magnetic Resonance Imaging Lesions in Wilson's Disease Following Penicillamine.
    Brum IV; Parmera JB; Otani RTV; Prates IR; Lucato LT; Cury RG; Barbosa ER
    Tremor Other Hyperkinet Mov (N Y); 2024; 14():9. PubMed ID: 38464913
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Wilson's disease.
    Ala A; Walker AP; Ashkan K; Dooley JS; Schilsky ML
    Lancet; 2007 Feb; 369(9559):397-408. PubMed ID: 17276780
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Treatment of Wilson's disease].
    Pépin B; Barraine R
    Cah Coll Med Hop Paris; 1968 Feb; 9(2):184-7. PubMed ID: 5745277
    [No Abstract]   [Full Text] [Related]  

  • 31. Evaluation of the Unified Wilson's Disease Rating Scale (UWDRS) in German patients with treated Wilson's disease.
    Leinweber B; Möller JC; Scherag A; Reuner U; Günther P; Lang CJ; Schmidt HH; Schrader C; Bandmann O; Czlonkowska A; Oertel WH; Hefter H
    Mov Disord; 2008 Jan; 23(1):54-62. PubMed ID: 17960799
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Penicillamine as a controversial treatment for Wilson's disease.
    LeWitt PA
    Mov Disord; 1999 Jul; 14(4):555-6. PubMed ID: 10435491
    [No Abstract]   [Full Text] [Related]  

  • 33. Copper chelation in patients with Wilson's disease. A comparison of penicillamine and triethylene tetramine dihydrochloride.
    Walshe JM
    Q J Med; 1973 Jul; 42(167):441-52. PubMed ID: 4728043
    [No Abstract]   [Full Text] [Related]  

  • 34. Resolution of cerebral white matter lesions following long-term penicillamine therapy for Wilson's disease: report of a case.
    Huang CC; Chu NS
    J Formos Med Assoc; 1992 Jun; 91(6):627-9. PubMed ID: 1358351
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The pattern of urinary copper excretion and its response to treatment in patients with Wilson's disease.
    Walshe JM
    QJM; 2011 Sep; 104(9):775-8. PubMed ID: 21622540
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Successful pregnancy after D-penicillamine therapy in a patient with Wilson's disease.
    Soong YK; Huang HY; Huang CC; Chu NS
    J Formos Med Assoc; 1991 Jul; 90(7):693-6. PubMed ID: 1681022
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Anatomo-clinical study of a case of Wilson's disease treated with chelating agents for 5 years].
    Boudin G; Pépin B; Milhaud M; Jérome H; Pacilly A
    Rev Neurol (Paris); 1968 Jan; 118(1):27-35. PubMed ID: 5697565
    [No Abstract]   [Full Text] [Related]  

  • 38. Wilson's disease and pregnancy.
    Sternlieb I
    Hepatology; 2000 Feb; 31(2):531-2. PubMed ID: 10655282
    [No Abstract]   [Full Text] [Related]  

  • 39. Compliant treatment with anti-copper agents prevents clinically overt Wilson's disease in pre-symptomatic patients.
    Dzieżyc K; Karliński M; Litwin T; Członkowska A
    Eur J Neurol; 2014 Feb; 21(2):332-7. PubMed ID: 24313946
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extensive striatal, cortical, and white matter brain MRI abnormalities in Wilson disease.
    Trocello JM; Woimant F; El Balkhi S; Guichard JP; Poupon J; Chappuis P; Feillet F
    Neurology; 2013 Oct; 81(17):1557. PubMed ID: 24145882
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.